Medable Inc., a leading cloud platform for patient-centered drug development, announced the first stage of the company’s European expansion plans with a new EMEA headquarters in Dublin.
World Health Organization emergencies head Michael Ryan urged countries on July 7 to use extreme caution when lifting Covid-19 restrictions so as “not to lose the gains you’ve made.”
Novartis will manufacture the anti-cholesterol medicine Leqvio at the company’s own plant in Austria to supply the United States as the Swiss drugmaker seeks U.S. approval that has been delayed by regulatory concerns over a contractor’s Italian facility.
The Euro 2020 soccer tournament was blamed for a surge in coronavirus cases as fans have flocked to stadiums, bars and spectator zones across Europe to watch the action while the pandemic still raged.
Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by U.S.-based Pacira BioSciences Inc. to provide strategic commercialization services for the company’s non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the UK, Germany, Sweden, Austria, the Netherlands and Finland.
EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, on May 6 announced key appointments across Europe to further strengthen the company’s worldwide market access and pricing solutions leadership position.
Americans had the lowest number of babies in more than four decades during 2020, mirroring a slump in European birth rates, as the Covid-19 pandemic forced more people to take care of sick family members or deal with job losses. Birth rate in the United States fell 4 percent in 2020 to about 3.6 million babies, the sixth straight annual decline and the lowest since 1979, according to the U.S. Centers for Disease Control and Prevention.
Germany’s CureVac, which is gearing up to publish results of a key Covid-19 vaccine trial, said U.S. export restrictions on key materials are making it impossible to predict the company’s short-term supply ramp-up in Europe.
European countries prepared on April 21 to resume deliveries of Johnson & Johnson’s Covid-19 vaccine and speed up the rollout after Europe’s drug regulator backed the shot.
Johnson & Johnson said on April 20 the company will resume rolling out its Covid-19 vaccine in Europe after the region’s medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.
